Explore popular drugs in clinical trials

Check which drugs are currently being frequently studied.

See also our rare diseases glossary and popular diseases list.

Starting by letter

To open the drugs glossary, select a letter from the list below.

Most popular drugs

The list below features the most popular substances currently involved in ongoing clinical trials.

Drug Trials
Pembrolizumab 451
Sodium Chloride 414
Carboplatin 340
Cisplatin 282
Paclitaxel 252
Fluorouracil 232
Oxaliplatin 223
Nivolumab 211
Dexamethasone 204
Rituximab 195
Cyclophosphamide 188
Durvalumab 162
Bevacizumab 161
Capecitabine 157
Paracetamol 156
Atezolizumab 146
Docetaxel 128
Prednisone 127
Tocilizumab 125
Prednisolone 121
Gemcitabine 117
Mycophenolate Mofetil 116
Venetoclax 116
Etoposide 115
Pemetrexed 114
Doxorubicin Hydrochloride 110
Infliximab 99
Lenalidomide 98
Semaglutide 91
Ipilimumab 90
Acetylsalicylic Acid 89
Folinic Acid 89
Placebo 85
Paclitaxel Albumin-Bound 84
Daratumumab 79
Cytarabine 79
Methotrexate 78
Calcium Folinate 78
Fludarabine Phosphate 77
Dapagliflozin 73
Letrozole 72
Bortezomib 72
Olaparib 70
Gemcitabine Hydrochloride 69
Obinutuzumab 68
Azacitidine 66
Trastuzumab 65
Cetuximab 64
Tacrolimus 63
Lenvatinib 63
Fulvestrant 62
Irinotecan 61
Methylprednisolone 60
Temozolomide 59
Irinotecan Hydrochloride Trihydrate 59
Cemiplimab 57
Vincristine Sulfate 57
Trastuzumab Deruxtecan 53
Apixaban 52
Enzalutamide 51
Betamethasone Sodium Phosphate 50
Lidocaine Hydrochloride Monohydrate 50
Dexamethasone Sodium Phosphate 49
Codeine Phosphate 49
Amoxicillin 48
Buclizine Hydrochloride 47
Lidocaine Hydrochloride 47
Exemestane 46
Hydrocortisone 46
Empagliflozin 46
Potassium Chloride 45
Anastrozole 45
Adalimumab 45
Ribociclib 44
Pomalidomide 43
Pertuzumab 43
Doxorubicin 43
Clavulanic Acid 42
Tenofovir Alafenamide 42
Oxygen 42
Clopidogrel 42
Rivaroxaban 41
Ibrutinib 41
Ruxolitinib 41
Ropivacaine Hydrochloride 40
Abemaciclib 40
Trimethoprim 40
Bendamustine Hydrochloride 40
Atorvastatin 40
Sulfamethoxazole 40
Metformin Hydrochloride 39
Carfilzomib 39
Cyclophosphamide Monohydrate 39
Palbociclib 38
Linezolid 38
Ifosfamide 38
Pemetrexed Disodium 38
Propofol 38
Vinorelbine 38
Emtricitabine 38

New drugs in trials

The list below features the new substances involved to ongoing clinical trials.

#1 VMX-C001

Clinical trials are studying VMX-C001 in people who take a Factor Xa direct oral anticoagulant and need urgent surgery or another high-bleeding-risk procedure.

1 month ago
#2 LIPASE

Clinical trials are investigating LIPASE, including a new lipase product compared with pancrelipase.

1 month ago
#3 TRIACYLGLYCEROL LIPASE

Clinical trials of TRIACYLGLYCEROL LIPASE are studying a new lipase treatment in adults with exocrine pancreatic insufficiency.

1 month ago
#4 IMA401

Clinical trials are investigating IMA401 in patients with recurrent and/or refractory solid tumors.

1 month ago
#5 ALLERGEN EXTRACTS

Clinical trials are studying BLOMIA TROPICALIS POLYMERIZED EXTRACT as part of a vaccine for dust mite and Blomia tropicalis allergy.

1 month ago
#6 AUR200

Clinical trials are investigating AUR200 in people with generalized myasthenia gravis.

1 month ago

Drugs starting by q

  • 10 

    Quavonlimab

    ,

    Quavonlimab is an investigational drug being studied in clinical trials for the treatment of advanced solid tumors, including non-small cell lung cancer (NSCLC). These trials are exploring how Quavonlimab works in combination with other cancer drugs, particularly pembrolizumab, to potentially improve outcomes for patients with advanced cancers. The studies are evaluating the safety, effectiveness, and optimal dosing of these drug combinations in different patient groups.

  • Quc398

    ,

    A groundbreaking clinical trial is underway to investigate the potential benefits of QUC398, a new drug designed to address knee osteoarthritis. This study aims to evaluate the drug’s effectiveness in reducing pain, preserving cartilage, and improving overall knee function in patients suffering from this common joint condition. The trial’s results could pave the way for a novel treatment option for those struggling with knee osteoarthritis.

  • Quemliclustat

    ,

    This article explores the use of Quemliclustat, an innovative drug, in various clinical trials for cancer treatment. Quemliclustat, also known as AB680, is being studied in combination with other drugs and therapies to potentially enhance the body’s immune response against different types of cancer. These trials aim to evaluate the safety, efficacy, and potential benefits of Quemliclustat in treating advanced cancers, including pancreatic, prostate, and gastrointestinal malignancies.

  • Quercetin

    , , ,

    Quercetin, a naturally occurring flavonoid found in various plants and fruits, has been the subject of numerous clinical trials investigating its potential therapeutic effects. These studies have explored quercetin’s role in treating a wide range of conditions, including gastroesophageal reflux disease (GERD), chronic obstructive pulmonary disease (COPD), coronary artery disease, post-operative pain, and even COVID-19. This article summarizes the key findings from recent clinical trials, highlighting the promising applications of quercetin in medical research.

  • Quercus Ilex Allergen Extract

    ,

    This article discusses a clinical trial investigating the use of Quercus Ilex (Holm Oak) allergen extract in diagnosing oak pollen allergy. The study aims to determine the optimal concentration of the extract that produces a skin reaction equivalent to a standard histamine solution, potentially improving the accuracy of allergy testing for patients with oak pollen sensitivities.

  • Quercus Robur Pollen Extract

    ,

    This article discusses a clinical trial investigating the use of Quercus Robur (Oak) Pollen Extract in diagnosing oak pollen allergies. The study aims to determine the effectiveness of this extract in skin prick tests, which are commonly used to identify allergies. This research is important for improving the accuracy of oak pollen allergy diagnoses and potentially enhancing treatment options for those affected.

  • Quetiapine

    ,

    Quetiapine, also known by its brand name Seroquel, is an antipsychotic medication that has been studied in various clinical trials for its potential benefits in treating different mental health conditions. These trials have explored its use in schizophrenia, bipolar disorder, major depressive disorder, and other psychiatric conditions. The studies have examined different formulations, dosages, and patient populations to better understand quetiapine’s effectiveness, safety profile, and optimal use in clinical practice.

  • Quinapril Hydrochloride

    , ,

    This article explores the use of Quinapril Hydrochloride in clinical trials for treating hypertension (high blood pressure) and improving cardiovascular health. Quinapril Hydrochloride is a medication that belongs to a class of drugs called ACE inhibitors, which help relax blood vessels and lower blood pressure. We’ll examine various studies that have investigated the efficacy, safety, and potential benefits of Quinapril Hydrochloride, both alone and in combination with other medications, for patients with mild to moderate hypertension and related conditions.

  • Quinidine Sulfate

    ,

    Quinidine sulfate, a medication primarily known for its antiarrhythmic properties, has been the subject of several clinical trials exploring its potential uses in various medical conditions. These trials aim to investigate the drug’s efficacy, safety, and interactions with other medications. The studies cover a range of applications, from treating heart rhythm disorders to potential benefits in neurological conditions and drug interactions.

  • Quinine Dihydrochloride

    This article discusses the use of Quinine Dihydrochloride in clinical trials for Parkinson’s Disease (PD). While the primary focus of the trial is on another drug called Fasudil, Quinine Dihydrochloride is mentioned as a comparator or reference drug. The study aims to evaluate the safety, tolerability, and potential efficacy of these medications in managing PD symptoms.

  • Quizartinib Dihydrochloride

    , ,

    Quizartinib Dihydrochloride, also known as Quizartinib, is a drug currently being studied in clinical trials for the treatment of acute myeloid leukemia (AML), particularly in patients with FLT3-ITD mutations. This article explores the ongoing research and potential benefits of Quizartinib in treating this aggressive form of blood cancer.